Gain Therapeutics, Inc. Common Stock

GANX us
$1.78
▼ 0.06 (-3.26%)
Volume: 382,887 · 2026-09-25

📈 Price Chart

Loading…
RSI (14)

🧭 Style Verdicts

🚀 Momentum 48
  • 21d momentum -1.7%
  • RSI 47
🎯 Pullback 50
  • -0.6% vs 20MA
💎 Value 58
  • -59% off 52w high

Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.

📐 Technicals

RSI(14)47.0
MACD+0.009
MA trendMixed
ATR5.24%
21d mom.-1.7%
63d mom.+1.7%
vs 20MA-0.6%
RVOL(20)1.10×
52w low · 2 52w high · 4
-59.0% from 52-week high
20d support 2 · resistance 2

Computed live from daily OHLCV · as of 2026-09-25

🏦 Fundamentals

Market cap$80M
PER—
PBR7.11
PSR—
EPS$-0.46
ROE-178.1%
ROA-130.4%
Dividend yield0.00%
Debt/Equity0.03
EV/EBITDA-3.52
week1M3M6M1YYTD
+1.14% -1.66% +1.71% -5.82% +2.30% -44.03%

Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.

⚖️ AI Bull vs Bear

🐂 Bull
5/10
🐻 Bear
7/10

14d momentum -1.11%, daily vol 3.07%. Gain Therapeutics, Inc. Common Stock sits in a bearish regime.

Derived from 14-day momentum and daily volatility on real OHLCV.

🗞 Related News

No recent news.